Gardner Lewis Asset Management’s Medicines Co MDCO Stock Holding History

Gardner Lewis Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-517,519	Closed	-$44M	–	99
2019 Q4	$44M	Buy	+517,519	New	+$34.5M	5.99%	4

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Gardner Lewis Asset Management's MDCO Position: Q1 2020 in Review

Gardner Lewis Asset Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 517,519 shares — an estimated $44M sold.

Gardner Lewis Asset Management first reported a position in MDCO in Q4 2019 and held it in 1 quarter. The position peaked at $44M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Gardner Lewis Asset Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Gardner Lewis Asset Management sold 517,519 Medicines Co shares in Q1 2020, an estimated $44M.
Gardner Lewis Asset Management first reported a position in Medicines Co in Q4 2019 and held it in 1 quarter.
Gardner Lewis Asset Management's Medicines Co position peaked at $44M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Gardner Lewis Asset Management's 13F filing for Q1 2020, filed 15 May 2020.